Results 141 to 150 of about 45,310 (237)

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 11, Page 1819-1830, November 2026.
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern, Simon Francis Thomsen, Georgios Kokolakis, Maurizio Podda, Gregor B. E. Jemec, Kurt Gebauer, Claus Zachariae, John Frew, Pablo Fernandez‐Peñas, Falk G. Bechara, Stefan Beissert, Sourabh Malandkar, Karen Scalzo‐Inguanti, Partha Nandy, Selvakumar Sukumar   +14 more
wiley   +1 more source

HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort

, 2019
We aimed to assess the mRNA expression of MHC class 1-related molecules in ankylosing spondylitis (AS) patients vs healthy controls (HCs) and, subsequently, if the absence of HLA-C*07 is associated with genetic susceptibility to axial spondyloarthritis ...
Winter, J.J. de, Blijdorp, I.C., Sande, M.G. van de, Iris C. Blijdorp, Henriëtte M. de Jong, Denis Poddubnyy, Janneke J. de Winter, Jürgen Sauter, Alexander H. Schmidt, Dominique L. Baeten, Baeten, D.L., Floris A. van Gaalen, Désirée van der Heijde, Nataliya G. Yeremenko, Gaalen, F.A. van, Poddubnyy, D., Marleen G. van de Sande, Schmidt, A.H., Yeremenko, N.G., Heijde, D. van der, Jong, H.M. de, Sauter, J.   +21 more
core   +1 more source

Calprotectin and spondyloarthritis [PDF]

Expert Review of Clinical Immunology, 2017
Daniel, Wendling, Frank, Verhoeven, Clément, Prati   +2 more
openaire   +2 more sources

Evaluation of the predictive validity of the ASAS axial spondyloarthritis criteria in the DESIR cohort.

, 2019
International audienceTo evaluate the predictive validity of the Assessment of SpondyloArthritis international Society (ASAS) axial spondyloarthritis (axSpA), Amor, European Spondylarthropathy Study Group (ESSG) and modified New York (mNY) classification
Dougados, Maxime, Meghnathi, Bhowmik, Moltó, Anna, Saraux, Alain   +3 more
core   +1 more source

Comparative analysis of instruments measuring peripheral arthritis activity in Spondyloarthritis: a measurement properties study in 13 RCTs. [PDF]

RMD Open
Capelusnik D, López-Medina C, Webers C, Ortolan A, van der Heijde D, Landewé R, Mease PJ, Molto A, Ramiro S.   +8 more
europepmc   +1 more source

Spondyloarthritis

Vempala M, Bankole AA, Maher L.
europepmc   +3 more sources

Diagnosis of ankylosing spondylitis: A bibliometric review from 2008 to 2024. [PDF]

Medicine (Baltimore)
Qiu Z, Xia R, Chen K, Yang Z, Chen Z, Yang K.   +5 more
europepmc   +1 more source

Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials. [PDF]

Rheumatology (Oxford)
Rudwaleit M, Ramiro S, Poddubnyy D, Magrey M, van der Horst-Bruinsma IE, Deodhar A, Taieb V, Kavanagh S, de Peyrecave N, Gensler LS.   +9 more
europepmc   +1 more source

ASAS Versus Modified New York Criteria for Ankylosing Spondylitis and Axial Spondyloarthritis: Attitudes and Utilization Among Saudi Rheumatologists. [PDF]

Healthcare (Basel)
Alammari YM, Al-Fahd AZ, Almukhalafi OA, Al-Tayar NR, Alshehri AM, Alsharif SA, Almhesen FN, Qutob RA, Alhajery MA, Alotay AA, Alanazi AM, Daghistani Y.   +11 more
europepmc   +1 more source

Ustekinumab for Extraintestinal Manifestations in Patients With Inflammatory Bowel Disease: Lessons From the TENOR Real-World Study. [PDF]

Gastro Hep Adv
Altwegg R, Corinne M, Carle P, Katia S, Christel B, Laurent PB.   +5 more
europepmc   +1 more source